When is dual bronchodilation indicated in COPD?

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, August 2017

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (70th percentile)
Good Attention Score compared to outputs of the same age and source (65th percentile)

Mentioned by

twitter: 7 tweeters

facebook: 1 Facebook page

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 20 Mendeley

Summary Twitter Facebook Dimensions citations

So far, Dimensions has found 11 publications that cite this research output.

11

The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.

Personalized and Typical Concurrent Risk of Limitations in Social Activity and Mobility in Older Persons with Multiple Chronic Conditions and Polypharmacy

Article in Annals of Epidemiology (September 2019)

Indacaterol/glycopyrronium versus tiotropium or glycopyrronium in long‐acting bronchodilator‐naïve COPD patients: A pooled analysis

Article in Respirology (July 2019)

Pharmacological Profile of AZD8871 (LAS191351), a Novel Inhaled Dual M3 Receptor Antagonist/β2-Adrenoceptor Agonist Molecule with Long-Lasting Effects and Favorable Safety Profile

Article in Journal of Pharmacology and Experimental Therapeutics (July 2019)